wire - news in brief
« BACK
Health - Materials Science - 03.04.2020
Health - Pharmacology - 03.04.2020 
Coalition Launched to Accelerate Research on the Prevention and Treatment of COVID-19 in Low- and Middle-Income Countries
A group of scientists, physicians, funders, and policy makers from over 70 institutions from over 30 countries have launched an international coalition to respond to COVID-19 in resource-poor settings.
Materials Science - Health - 03.04.2020 
Antiviral treatment for textiles
An ETH spin-off has developed a new treatment for textiles that reduces viral infectivity on treated surfaces. The technology can be used for face masks and other textile products. Recently, the ETH spin-off HeiQ Materials presented an innovative antiviral and antibacterial treatment for textiles, which has been tested effectively against coronavirus, for example.
Pharmacology - Health - 02.04.2020
Health - 02.04.2020 
Swiss TPH Doctors Support the University Hospital Basel in Fight against COVID-19
During the corona crisis, the University Hospital Basel has converted the Prediger church into a Corona Test Centre where every day, hundreds of people are tested for the corona virus.
Health - Life Sciences - 02.04.2020 
Tackling the virus through creativity
ETH Zurich has been in lockdown for more than two weeks now. Although many projects have been put on hold, research relevant to the coronavirus has gathered speed.
Health - 31.03.2020
Health - Pharmacology - 31.03.2020
Health - 31.03.2020
Health - Life Sciences - 31.03.2020 
"When it comes to infectious diseases, we're still vulnerable"
An EPFL professor of Microbiology, Melanie Blokesch reminds us why we need to take infectious diseases more seriously - and be better prepared for future outbreaks.
Administration - Health - 31.03.2020
Health - Life Sciences - 30.03.2020 
"The world now has no choice but to count on science."
Jacques Fellay, a professor at EPFL's School of Life Sciences, talks about mutations of the novel coronavirus, variants in the human genome, and how they might affect the current pandemic. Has the SARS-CoV-2 virus mutated by now? Like all viruses, SARS-CoV-2 evolves over time through random mutations of its genome (which is made of single-stranded RNA).
Health - 30.03.2020 
New UZH Coronavirus Test Center Relieves Strain on Family Doctors
The University of Zurich has repurposed its Travel Clinic as a COVID-19 test center. Designed to complement the tests currently offered by family doctors in Canton Zurich, it is geared to other people who work in healthcare services.
Pharmacology - Health - 28.03.2020
Pharmacology - Health - 27.03.2020
Health - 27.03.2020
Pharmacology - Health - 27.03.2020
Health - 27.03.2020
Health - Pharmacology - 26.03.2020 
"In a crisis like this, an antiviral drug could buy us some time"
Francesco Stellacci, a professor in EPFL's School of Engineering, discusses his research in the field of nanomedicine and how it could help us get past the coronavirus crisis.
Health - 26.03.2020
Life Sciences - Health - 24.03.2020
Life Sciences - Health - 24.03.2020
Pharmacology - Health - 24.03.2020
Pharmacology - Health - 24.03.2020
Pharmacology - Health - 20.03.2020
Health - 19.03.2020
Pharmacology - Health - 19.03.2020
Pharmacology - Health - 18.03.2020
Health - 18.03.2020 
Knowns and unknowns about the new coronavirus
Didier Trono, a professor at EPFL's Laboratory of Virology and Genetics, answers some common questions about SARS CoV-2 and the disease it causes, COVID-19. We know that the new coronavirus can cause lung infections that can be fatal for elderly people and those already suffering from heart disease, respiratory problems or weakened immune systems.
Health - 18.03.2020 
An Innovative Approach to Improving Young People’s Mental Health
Mental illness in early life can have a devastating effect on the future of young people, which in turn influences the mental wealth of societies around the globe.
Health - Environment - 18.03.2020 
Exposome Research to Improve People’s Health in Urban Settings
By 2030, more than 80% of Europe's population will live and interact within a complex urban environment, consisting of a mixture of social and environmental factors.
Pharmacology - Health - 17.03.2020
Health - Life Sciences - 16.03.2020
Health - Pharmacology - 13.03.2020 
Heading home with a rehab robot
Hands are our most important tools. Many stroke survivors struggle with a serious loss of function in their affected hand. ETH researchers are developing innovative solutions to help people in rehabilitation - and in everyday life. Hands are our most important tools. Many stroke survivors struggle with a serious loss of motor function in their affected hand.
Health - Pharmacology - 13.03.2020 
"We take rehabilitation to also mean inclusion."
ETH Zurich aims to step up rehabilitation research and education with the Rehab Initiative. But how are the needs of people with disabilities best met' To discuss the issues, we hosted a roundtable with a physician, a person with a disability and a researcher.
Life Sciences - Health - 12.03.2020 
To protect your brain, don’t be (too) kind!
Using brain imaging, a team from the University of Geneva and the HUG show that elderly people with low agreeableness are better protected against Alzheimer's disease.
Health - Pharmacology - 11.03.2020
Health - Life Sciences - 11.03.2020
Health - Life Sciences - 10.03.2020 
Interview: "The Legionella problem is multidimensional"
Why is Eawag addressing the topic of legionella? Firstly, the FOPH data clearly shows that legionella is a growing problem throughout Switzerland.
Health - 10.03.2020
Health - Life Sciences - 09.03.2020
Health - 03.03.2020
Health - Environment - 03.03.2020
Health - Environment - 03.03.2020 
Legionella control efforts intensified in Switzerland - new "LeCo" project launched
Legionnaires' disease is becoming more common in Switzerland: 582 cases were recorded by the Federal Office of Public Health (FOPH) in 2019 - twice as many as in 2013.
Pharmacology - Health - 03.03.2020
Environment - Health - 28.02.2020
Health - Pharmacology - 27.02.2020
Pharmacology - Health - 25.02.2020
Health - Life Sciences - 24.02.2020
Health
Results 1 - 50 of 1783.
A group of scientists, physicians, funders, and policy makers from over 70 institutions from over 30 countries have launched an international coalition to respond to COVID-19 in resource-poor settings.
An ETH spin-off has developed a new treatment for textiles that reduces viral infectivity on treated surfaces. The technology can be used for face masks and other textile products. Recently, the ETH spin-off HeiQ Materials presented an innovative antiviral and antibacterial treatment for textiles, which has been tested effectively against coronavirus, for example.
During the corona crisis, the University Hospital Basel has converted the Prediger church into a Corona Test Centre where every day, hundreds of people are tested for the corona virus.
ETH Zurich has been in lockdown for more than two weeks now. Although many projects have been put on hold, research relevant to the coronavirus has gathered speed.
On the trail of the virus
Participate in containing coronavirus: medical informatics specialists at ETH Zurich have developed a monitoring system to complement corona tests and track how the virus is spreading in Switzerland. All residents of Switzerland can take part in the online survey. How quickly is coronavirus spreading in Switzerland?
Participate in containing coronavirus: medical informatics specialists at ETH Zurich have developed a monitoring system to complement corona tests and track how the virus is spreading in Switzerland. All residents of Switzerland can take part in the online survey. How quickly is coronavirus spreading in Switzerland?
An EPFL professor of Microbiology, Melanie Blokesch reminds us why we need to take infectious diseases more seriously - and be better prepared for future outbreaks.
Coronavirus: Confederation appoints scientific advisory board
In the current crisis, the federal government wants to exploit the potential available in the Swiss scientific community to an even greater extent by working with scientists to find the best approach to overcoming the pandemic.
In the current crisis, the federal government wants to exploit the potential available in the Swiss scientific community to an even greater extent by working with scientists to find the best approach to overcoming the pandemic.
Jacques Fellay, a professor at EPFL's School of Life Sciences, talks about mutations of the novel coronavirus, variants in the human genome, and how they might affect the current pandemic. Has the SARS-CoV-2 virus mutated by now? Like all viruses, SARS-CoV-2 evolves over time through random mutations of its genome (which is made of single-stranded RNA).
The University of Zurich has repurposed its Travel Clinic as a COVID-19 test center. Designed to complement the tests currently offered by family doctors in Canton Zurich, it is geared to other people who work in healthcare services.
Novartis new analysis further shows durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment
Patients & Caregivers Healthcare Professionals Society & ESG Prespecified analysis of pooled data from ORION-9, -10 and -11 Phase III clinical trials shows inclisiran reduced low-density lipo
Patients & Caregivers Healthcare Professionals Society & ESG Prespecified analysis of pooled data from ORION-9, -10 and -11 Phase III clinical trials shows inclisiran reduced low-density lipo
Novartis Cosentyx gains positive CHMP opinion for new indication in the axial spondyloarthritis spectrum
Patients & Caregivers Healthcare Professionals Society & ESG EMA CHMP positive opinion in non-radiographic axial spondyloarthritis (nr-axSpA) paves way for fourth indication in Europe, and is
Patients & Caregivers Healthcare Professionals Society & ESG EMA CHMP positive opinion in non-radiographic axial spondyloarthritis (nr-axSpA) paves way for fourth indication in Europe, and is
Francesco Stellacci, a professor in EPFL's School of Engineering, discusses his research in the field of nanomedicine and how it could help us get past the coronavirus crisis.
Vital support for Swiss hospitals
The expected surge in coronavirus patients is pushing Swiss hospitals to the very limits of their capacity. Equipment, consumables and other resources are desperately needed. Researchers right across Switzerland can provide valuable support through pooled resources. The ETH Domain has set up a dedicated platform "Academic Resources for COVID" to coordinate their efforts.
The expected surge in coronavirus patients is pushing Swiss hospitals to the very limits of their capacity. Equipment, consumables and other resources are desperately needed. Researchers right across Switzerland can provide valuable support through pooled resources. The ETH Domain has set up a dedicated platform "Academic Resources for COVID" to coordinate their efforts.
ETH makes laboratory equipment available for coronavirus tests
Coronavirus testing is an essential part of identifying infected people and curbing the spread of the pandemic. To speed up the testing process, the Department of Environmental Systems Science at ETH Zurich has made its laboratory equipment available to the canton of Thurgau. The first step of a coronavirus test is to swab the person's mouth, nose or throat.
Coronavirus testing is an essential part of identifying infected people and curbing the spread of the pandemic. To speed up the testing process, the Department of Environmental Systems Science at ETH Zurich has made its laboratory equipment available to the canton of Thurgau. The first step of a coronavirus test is to swab the person's mouth, nose or throat.
Zolgensma data shows rapid, significant, clinically meaningful benefit in SMA including prolonged event-free survival, motor milestone achievement and durability now up to 5 years post-dosing
Patients & Caregivers Healthcare Professionals Society & ESG Interim SPR1NT data showed presymptomatic babies with SMA treated with Zolgensma (onasemnogene abeparvovec-xioi) soon after birth
Patients & Caregivers Healthcare Professionals Society & ESG Interim SPR1NT data showed presymptomatic babies with SMA treated with Zolgensma (onasemnogene abeparvovec-xioi) soon after birth
Didier Trono, a professor at EPFL's Laboratory of Virology and Genetics, answers some common questions about SARS CoV-2 and the disease it causes, COVID-19. We know that the new coronavirus can cause lung infections that can be fatal for elderly people and those already suffering from heart disease, respiratory problems or weakened immune systems.
Mental illness in early life can have a devastating effect on the future of young people, which in turn influences the mental wealth of societies around the globe.
By 2030, more than 80% of Europe's population will live and interact within a complex urban environment, consisting of a mixture of social and environmental factors.
Getting groundbreaking medical technology out of the lab
New medical technologies hold immense promise for treating a range of conditions. Despite the pace of innovation in the medtech field, however, most discoveries never make it out of the laboratory. New research from EPFL could fast-track the route to clinical translation. Advances in materials, microfabrication and medical imaging are accelerating the pace of innovation in implantable neuroprosthetics.
New medical technologies hold immense promise for treating a range of conditions. Despite the pace of innovation in the medtech field, however, most discoveries never make it out of the laboratory. New research from EPFL could fast-track the route to clinical translation. Advances in materials, microfabrication and medical imaging are accelerating the pace of innovation in implantable neuroprosthetics.
Hands are our most important tools. Many stroke survivors struggle with a serious loss of function in their affected hand. ETH researchers are developing innovative solutions to help people in rehabilitation - and in everyday life. Hands are our most important tools. Many stroke survivors struggle with a serious loss of motor function in their affected hand.
ETH Zurich aims to step up rehabilitation research and education with the Rehab Initiative. But how are the needs of people with disabilities best met' To discuss the issues, we hosted a roundtable with a physician, a person with a disability and a researcher.
Using brain imaging, a team from the University of Geneva and the HUG show that elderly people with low agreeableness are better protected against Alzheimer's disease.
COVID-19: IRB receives EU emergency research funding
Following the publication of a ¤10 million call in January, the European Commission has secured an additional ¤37.5 million for urgently needed research on COVID-19 vaccine development, treatment and diagnostics.
Following the publication of a ¤10 million call in January, the European Commission has secured an additional ¤37.5 million for urgently needed research on COVID-19 vaccine development, treatment and diagnostics.
Why is Eawag addressing the topic of legionella? Firstly, the FOPH data clearly shows that legionella is a growing problem throughout Switzerland.
Legionnaires' disease is becoming more common in Switzerland: 582 cases were recorded by the Federal Office of Public Health (FOPH) in 2019 - twice as many as in 2013.
